Trial Profile

Clinical Evaluation of Ropinirole IR Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration).

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 29 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

13 Oct 2011 Study terminated due to recruitment problems as reported by ClinicalTrials.gov.
16 Jul 2010 Actual patient number is 34 as reported by ClinicalTrials.gov.
16 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com